Related references
Note: Only part of the references are listed.The role of polytherapy in the management of epilepsy: suggestions for rational antiepileptic drug selection
Alberto Verrotti et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2020)
Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial
Gregory L. Krauss et al.
LANCET NEUROLOGY (2020)
Cenobamate (YKP3089) as adjunctive treatment for uncontrolled focal seizures in a large, phase 3, multicenter, open-label safety study
Michael R. Sperling et al.
EPILEPSIA (2020)
Randomized phase 2 study of adjunctive cenobamate in patients with uncontrolled focal seizures
Steve S. Chung et al.
NEUROLOGY (2020)
Positive allosteric modulation of GABAA receptors by a novel antiepileptic drug cenobamate
Ramesh Sharma et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multi-centre, double-blind, randomised, placebo-controlled, dose-response trial (vol 19, pg 38, 2020)
G. L. Krauss et al.
LANCET NEUROLOGY (2020)
Effects of cenobamate (YKP3089), a newly developed anti-epileptic drug, on voltage-gated sodium channels in rat hippocampal CA3 neurons
Michiko Nakamura et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Questioning the Effectiveness of Newer Antiseizure Medications
W. Allen Hauser
JAMA NEUROLOGY (2018)
Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs A 30-Year Longitudinal Cohort Study
Zhibin Chen et al.
JAMA NEUROLOGY (2018)
Identification of patients who will not achieve seizure remission within 5 years on AEDs
David M. Hughes et al.
NEUROLOGY (2018)
The burden of premature mortality of epilepsy in high-income countries: A systematic review from the Mortality Task Force of the International League Against Epilepsy
David J. Thurman et al.
EPILEPSIA (2017)
The impact of seizures on epilepsy outcomes: A national, community-based survey
Colin B. Josephson et al.
EPILEPSIA (2017)
Drug development for refractory epilepsy: The past 25 years and beyond
Ambica Golyala et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2017)
Quality improvement in neurology Epilepsy Update Quality Measurement Set
Nathan B. Fountain et al.
NEUROLOGY (2015)
The consequences of refractory epilepsy and its treatment
Kenneth D. Laxer et al.
EPILEPSY & BEHAVIOR (2014)
Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes
Tracy Glauser et al.
EPILEPSIA (2013)
Prognostic factors for time to treatment failure and time to 12 months of remission for patients with focal epilepsy: post-hoc, subgroup analyses of data from the SANAD trial
Laura Bonnett et al.
LANCET NEUROLOGY (2012)
Comparative efficacy of combination drug therapy in refractory epilepsy
Nicholas P. Poolos et al.
NEUROLOGY (2012)
Patterns of treatment response in newly diagnosed epilepsy
M. J. Brodie et al.
NEUROLOGY (2012)
Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies
Patrick Kwan et al.
EPILEPSIA (2010)
Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005-2009
Anne T. Berg et al.
EPILEPSIA (2010)
Quantifying the response to antiepileptic drugs
Yitzhak Schiller et al.
NEUROLOGY (2008)
Results of treatment changes in patients with apparently drug-resistant chronic epilepsy
Anna L. Luciano et al.
ANNALS OF NEUROLOGY (2007)
Cognitive effects of seizures
Guy Vingerhoets
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2006)
Seizure reduction and quality of life improvements in people with epilepsy
GL Birbeck et al.
EPILEPSIA (2002)
Share Paper
